Welcome : Guest

Heron Therapeutics, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Heron Therapeutics, Inc., which is principally involved in Biotechnology Business. Illustrated with 57 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

Code: PCP-30429
Price: $2850
Company Type: Public
Pages: 60
Date: June 2016
Market Data Tables: 57

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Clinical Trials......3
Table 1: Clinical Trials by Region Worldwide (2014) - Percentage Market Share Breakdown by Value for Africa, Asia, Australia, Canada, Europe, Mexico, South America, and United States......3
5-HT3 Antagonist......4
Table 2: 5-HT3 Antagonist Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for GRANISETRON, ONDANSETRON AND PALONOSETRON (ALOXI)......4
Extended-Release Opioid......5
Table 3: Extended-Release Opioid Market by Payment Method in the US (2015) - Percentage Share Breakdown by Value for Cash, Commercial, Managed Medicaid, Medicaid and Medicare......5
Nausea and Vomiting Associated With Cancer Chemotherapy......6
Table 4: Nausea and Vomiting Associated With Cancer Chemotherapy Market by Drug in European Union (2015) - Percentage Share Breakdown by Value for Aprepitant (Emend), Netupitant (Akynzeo), and Rolapitant (Varubi)......6
CANCER Market......7
Table 5: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......7
Table 6: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......8
Table 7: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......9
Table 8: Hematological Cancer by Category Worldwide (2014) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......10
Table 9: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......11
Table 10: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......12
Table 11: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......13
Table 12: No. of Solid Cancer Tumor Patients by Type Worldwide (2014) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......14
Table 13: Number of Cancer Patients by Type Worldwide (2014) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......15
Table 14: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......16
Table 15: No. of Bladder Cancer Patients by Category in the US (2014) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......17
Table 16: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......18
Table 17: No. of Cancer Patients Death by Type in the US (2014) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......19
Anti-Cancer Drugs......20
Table 18: Anti-Cancer Drugs Market by Product Type in China (2014) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......20
Table 19: Anti-Cancer Drugs Market by Type in China (2014) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......21
Plasma Market......22
Table 20: Plasma Market by Product Worldwide (2015) - Percentage Breakdown by Value for Albumin, Factor IX, Factor VIII, Hyperimmunes, Intravenous Immunoglobulin (IVIG), and Others......22
Table 21: Plasma Market by Products (excluding Recombinant Factors) Worldwide (2015) - Percentage Share Breakdown by Value for Albumin, Factor VIII, Intravenous Immunoglobulin (IVIG) and Others......23
Table 22: Plasma Market by Region (excluding Recombinant Factors) Worldwide (2015) - Percentage Share Breakdown by Value for Asia-Pacific, Europe, North America and Others......24
Table 23: Blood Plasma Composition by Category Worldwide (2015) - Percentage Share Breakdown by Volume for Protein, Water, and Other......25
Table 24: Plasma Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Asia, Europe, and Middle East, USA, and Others......26
Table 25: Plasma-Derived Therapeutic Demand by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Europe, USA, and Rest of World......27
Table 26: Plasma Market by Segment in China (2014) - Percentage Share Breakdown by Value for Alpha-1 proteinase inhibitor (A1PI), Coagulation Factor IX, Coagulation Factor VIII, Fibrinogen, Human Albumin, Immunoglobulin for Intramuscular Injection, Intravenous Immunoglobulin (IVIG), Prothrombin Complex, and Specific Immunoglobulin......28
Table 27: Plasma-Based Product Market by Type in China (2014) - Percentage Share Breakdown by Value for Blood Coagulation Factor, Human Albumin, Human Immunoglobin, Hyperimmunes, and Others......29
Table 28: Plasma Products Consumption by Type in the US (2014) - Percentage Share Breakdown by Volume for Albumin, Factor IX (Plasma), Factor VIII, Hyperimmunes (IM&IV), and Intravenous Immunoglobulin (IVIG), and Others......30
Injectables......31
Table 29: Injectables Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Biologics, Standard Injectables, Vaccines and Others......31
Table 30: Standard Injectables Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Anti-Infectives, Blood, Oncology and Others......32
Table 31: Injectable Products Market by Type in Europe (2014) - Percentage Breakdown by Value Sales for Biologics, Biosimilars, Branded Injectables and Generic Injectables......33
Chronic Diseases......34
Table 32: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......34
Table 33: No. of Chronic Obstructive Pulmonary Disease (COPD) Patients Worldwide (2014) - Percentage Market Share Breakdown for Europe, North America, and Rest of World......35
Table 34: Chronic Obstructive Pulmonary Disease (COPD) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Long Acting Muscarinic Antagonists (LAMA), Long Acting Muscarinic Antagonists (LAMA) and Long Acting β2-Agonists (LABA), and Long Acting β2-Agonists (LABA) and Inhaled Corticosteroid (ICS)......36
Table 35: Chronic Kidney Disease Market by Drug in the US (2014) - Percentage Share Breakdown by Value Sales for Aranesp and Others......37
Chronic Lymphocytic Leukemia (CLL) (1L) Patients......38
Table 36: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2014) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......38
Table 37: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2014) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......39
Table 38: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2014) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......40
Table 39: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2014) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......41
Breast Cancer Drugs......42
Table 40: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......42
Injectables......43
Table 41: Market Shares of Leading Generic Injectable Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Fresenius SE & Co., Hikma Pharmaceuticals, Hospira, Inc., Luitpold Pharmaceuticals, Inc. and Others......43
Table 42: Market Shares of Leading Injectable Manufacturers by Value Sales in France (2014) - Percentage Breakdown for Aguettant Limited, Baxter International, Inc., B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., Lake Forest Park Medical Clinic (LFP), Mylan Laboratories, Inc., Novartis International AG (Sandoz), Laboratoires PANPHARMA S.A., Sanofi S.A., and Others......44
Table 43: Market Shares of Leading Injectable Manufacturers by Value Sales in Germany (2014) - Percentage Breakdown for AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Medac GmbH, Novartis International AG (Sandoz), Sanofi S.A.,Teva Pharmaceutical Industries Ltd. and Others......45
Table 44: Market Shares of Leading Injectable Manufacturers by Value Sales in Italy (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Hospira, Inc., Johnson & Johnson, KEDRION GROUP S.p.A., Novartis International AG (Sandoz), Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd. and Others......46
Table 45: Market Shares of Leading Injectable Manufacturers by Value Sales in Spain (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Ges Genericos Españoles Laboratorio S.A., Grifols, S.A, Hospira, Inc., Johnson & Johnson, Normon S.A., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......47
Table 46: Market Shares of Leading Auto Injector Manufacturers by Value Sales in Taiwan (2014) - Percentage Breakdown for Sonic Healthcare Limited (SHL), and Others......48
Table 47: Market Shares of Leading Injectable Manufacturers by Value Sales in the UK (2014) - Percentage Breakdown for Actavis Plc (Watson), AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Hospira, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......49
Chemotherapy-Induced Thrombocytopenia (CIT)......50
Table 48: Market Shares of Leading Drugs for the Treatment of Chemotherapy-Induced Thrombocytopenia (CIT) in China (2015) - Percentage Share Breakdown by Value for Baijieyi, Juheli, Recombinant Human Thrombopoietin, Te Er Kang and Others......50
Opioids......51
Table 49: Market Shares of Leading Opioids Brands Worldwide (2015) - Percentage Share Breakdown by Value for Codeine, Hydrocodone, Oxycodone and Others......51
Pain Remedies......52
Table 50: Market Shares of Leading Pain Management Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Endo International Plc, Johnson & Johnson, Pfizer, Inc., and Others......52
Table 51: Market Shares of Leading Plasma Companies in China (2014) - Percentage Share Breakdown by Volume for Chengdu Rongsheng Pharmaceuticals Co., Ltd., China Biologic Products, Inc., Hualan Biological Engineering, Inc., Shanxi Kangbao Biological Product Co., Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., Tonglu Biological Pharmaceutical Co., Ltd., and Others......53
Table 52: Market Shares of Leading Pain Remedies Manufacturers for Over-the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for Bayer HealthCare AG, Johnson & Johnson Private Limited, Pfizer, Inc., Prestige Brands Holdings, Inc., Private-label and Others......54
Plasma Products......55
Table 53: Market Shares of Leading Plasma Companies Worldwide (2015) - Percentage Share Breakdown by Value for Baxter International, Inc., CSL Limited, Grifols, S.A. and Others......55
Table 54: Market Shares of Leading Plasma Derivative Companies Worldwide (2014) - Percentage Share Breakdown by Value for Baxter International, Inc., Biotest Pharmaceuticals Corporation, CSL, Ltd., Grilfols USA, Kedrion Biopharma, LFB, Octapharma AG, and Others......56
Table 55: Market Shares of Leading Plasma Companies in the US (2014) - Percentage Share Breakdown by Value for Baxter International, Inc., CSL Behring, Octapharma AG, Talecris Plasma Resources (Grifols, Inc.), and Others......57
Preclinical Pharmaceuticals......58
Table 56: Market Shares of Leading Preclinical Pharmaceutical Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Charles River Laboratories International, Inc. (CRL), Covance, Inc. (CVD), Pharmaceutical Product Development Inc. (PPDI), Wuxi Pharmatech (Cayman) Inc. (WX), and Others......58
Table 57: Heron Resources Ltd.’s Sales by Business Segment (2013-2014) in Percentage for Corporate and Others......59